Trials / Completed
CompletedNCT02500212
Pharmacokinetic Study of ENVARSUS in Adult De-novo Kidney Transplant Patients
OPEN-LABEL, MULTICENTRE, RANDOMIZED CLINICAL TRIAL TO COMPARE THE PHARMACOKINETICS OF ENVARSUS® TABLETS AND ADVAGRAF® CAPSULES ADMINISTERED ONCE DAILY IN ADULT DE-NOVO KIDNEY TRANSPLANT PATIENTS
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Chiesi Farmaceutici S.p.A. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Open-label, multicentre, randomized clinical trial to compare the pharmacokinetics of ENVARSUS® tablets and ADVAGRAF® capsules administered once daily in adult de-novo kidney transplant patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ENVARSUS® | |
| DRUG | ADVAGRAF® |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2016-06-01
- Completion
- 2016-06-01
- First posted
- 2015-07-16
- Last updated
- 2020-07-31
Locations
7 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02500212. Inclusion in this directory is not an endorsement.